Specify a stock or a cryptocurrency in the search bar to get a summary
ReproCell Inc
6RCReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons; 3D cell culture; and labware. The company also provides research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, diagnostic, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan. Address: MetLife Shin-Yokohama Building, Yokohama, Japan, 222-0033
Analytics
WallStreet Target Price
38 427.74 JPYP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 6RC
Dividend Analytics 6RC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 6RC
Stock Valuation 6RC
Financials 6RC
Results | 2019 | Dynamics |